Regenxbio awards CFO Mitchell Chan 24,305 restricted stock units
RGNX•Regenxbio granted CFO Mitchell Chan 24,305 shares of common stock on November 1, 2026.
1. Stock award
Regenxbio granted Chief Financial Officer Mitchell Chan 24,305 shares of common stock on November 1, 2026.




